Target intelligence / Profile preview

Apoptosis regulator Bcl-2 mRNA (BCL2 mRNA)

Target
BCL2 mRNA
Molecular classification
Other
01

Overview

Apoptosis regulator Bcl-2 mRNA is the messenger RNA transcript that encodes the B-cell lymphoma 2 (Bcl-2) protein, a critical outer mitochondrial membrane protein that acts as a key inhibitor of apoptosis. The Bcl-2 protein prevents programmed cell death by blocking the release of cytochrome c from the mitochondria, thereby promoting cell survival and contributing to chemotherapy resistance in various malignancies. Overexpression of Bcl-2 is a hallmark of many cancers, particularly hematological malignancies such as chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), and acute myeloid leukemia (AML), as well as solid tumors like melanoma and lung cancer. Targeting Bcl-2 at the pre-translational level using antisense oligonucleotides (ASOs) represents a therapeutic strategy to downregulate Bcl-2 protein expression and restore sensitivity to apoptotic stimuli. Investigational drugs such as oblimersen sodium (Genasense) and the liposomal formulation BP1002 are designed to hybridize specifically with Bcl-2 mRNA, leading to its degradation or translation inhibition. By reducing intracellular Bcl-2 protein levels, these therapies lower the threshold for cancer cells to undergo apoptosis, especially when combined with standard cytotoxic chemotherapies or other targeted agents.

Other names
B-cell lymphoma 2 mRNABCL2 mRNABCL-2 mRNAB-cell CLL/lymphoma 2 mRNAApoptosis regulator Bcl-2 messenger RNA
02

Mechanism of action

Antisense oligonucleotide binding to the initiation codon region of Bcl-2 mRNA, leading to RNase H-mediated cleavage or translational block, thereby reducing Bcl-2 protein expression and promoting apoptosis

03

Biological functions

ApoptosisCell deathCell proliferationOther
04

Disease associations

CancerOther
05

Safety considerations

ThrombocytopeniaInfusion-related reactionsOff-target hybridization effectsTransient liver enzyme elevationsTumor lysis syndromeRenal toxicity
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Bcl-2 protein expression levelBcl-2 mRNA expression levelCleaved caspase-3Cleaved PARP

Beyond the preview

Go deeper on Apoptosis regulator Bcl-2 mRNA (BCL2 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis regulator Bcl-2 mRNA (BCL2 mRNA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call